Dantron, also known as 1,8-dihydroxyanthraquinone or chrysazin, is an anthraquinone derivative primarily used as a stimulant laxative in palliative care settings to counteract opioid-induced constipation.… Read more
Dantron, also known as 1,8-dihydroxyanthraquinone or chrysazin, is an anthraquinone derivative primarily used as a stimulant laxative in palliative care settings to counteract opioid-induced constipation. To support the rigorous analytical demands of pharmaceutical research and manufacturing, this category provides essential reference standards, including the active pharmaceutical ingredient, related impurities, and stable isotope-labelled compounds. These high-quality materials are critical for laboratories performing impurity profiling, method validation, and routine quality control assays. By utilizing these characterized standards, researchers can accurately identify degradation products, ensure compliance with pharmacopeial specifications, and perform precise quantitative analysis throughout the drug development lifecycle. Accurate quantification and structural confirmation are vital for verifying the purity of batches and maintaining consistent therapeutic efficacy in clinical applications.